Back
Entrée Resources Ltd. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
16
ERLFF
Entrée Resources Ltd.
Last Price:
$1.52
Seasonality Move:
-0.63%
Sell
31
MNPR
Monopar Therapeutics, Inc.
Last Price:
$69.11
Seasonality Move:
25.93%
Sell
16
Entrée Resources Ltd. (ERLFF)
is a Sell
Is Entrée Resources Ltd. a Buy, Sell or Hold?
-
The current Entrée Resources Ltd. [ERLFF] share price is $1.56. The Score for ERLFF is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
-
ERLFF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
31
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $65.99. The Score for MNPR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ERLFF Stock Price Chart
What is Entrée Resources Ltd.'s stock price today?
-
The Entrée Resources Ltd. share price today is $1.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ERLFF is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $65.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
ERLFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 34.93 | Sell |
| Chaikin Money Flow: | -42556 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.59 - 1.69) | Sell |
| Bollinger Bands (100): | (1.55 - 1.69) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.42 | Sell |
| Relative Strength Index (14 RSI): | 32.25 | Sell |
| Chaikin Money Flow: | -36886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.08 - 86.32) | Sell |
| Bollinger Bands (100): | (45.17 - 89.09) | Sell |
ERLFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.64 | Sell |
| 20-day SMA: | 1.65 | Sell |
| 50-day SMA: | 1.65 | Sell |
| 200-day SMA: | 1.6 | Sell |
| 8-day EMA: | 1.62 | Sell |
| 20-day EMA: | 1.64 | Sell |
| 50-day EMA: | 1.63 | Sell |
| 200-day EMA: | 1.12 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.2 | Sell |
| 20-day SMA: | 79.37 | Sell |
| 50-day SMA: | 82.12 | Sell |
| 200-day SMA: | 52.13 | Buy |
| 8-day EMA: | 72.25 | Sell |
| 20-day EMA: | 76.67 | Sell |
| 50-day EMA: | 77.13 | Sell |
| 200-day EMA: | 56.56 | Buy |
Entrée Resources Ltd. Earnings Growth & ERLFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
Entrée Resources Ltd. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||